Construction and energy stocks drive the morning narrative, with Cupid rallying 8.2% on aggressive guidance and NLC India gaining 2.3% after securing a 265 MW battery storage bid. Fresh order wins across infrastructure add further momentum.

Jindal Stainless

• Product Launch: Supplied over 160 tonnes of grade 304L stainless steel for the structural reinforcement of Sadhana Bhawan, a heritage meditation hall, preserving its architectural character. Stock closed at ₹747.40 in the previous session, up 1.23%.
• Corporate Action: Redeemed ₹99 crore worth of Non-Convertible Debentures (NCDs) at maturity, including a final interest payment of ₹8.53 crore.
• Partnership: Signed an MoU with Nasscom to upskill employees in AI, Big Data, and Cybersecurity, supporting Smart Factory 4.0 initiatives at Hisar and Jajpur units.

Tech Mahindra

• Corporate Action: The board is set to consider a proposal for issuing bonus shares to shareholders from accumulated reserves. Stock closed at ₹1,524.00 in the previous session, up 0.89%.
• Deal: Partnered with Verato to integrate MDM Cloud into healthcare transformation services, aiming to resolve fragmented patient data issues for US clients.

Blue Dart Express

• Pricing: Announced a 9-12% hike in domestic service prices effective January 1, 2027, citing rising labour and utility costs. Stock closed at ₹4,629.00 in the previous session, up 1.16%.
• Dividend: Shareholders approved a dividend of ₹25 per equity share for FY26, alongside the appointment of three new directors.

Interarch Building Solutions

• Order Book: Secured a confirmed work order worth ₹89 crore for a data centre project involving pre-engineered steel structures. Stock closed at ₹1,673.40 in the previous session, down 0.99%.
• Guidance: Raised FY28 revenue guidance to ₹2,700 crore from ₹2,500 crore, reflecting increased confidence in medium-term outlook.
• Capacity Expansion: Commissioned a new 24,000 MT heavy steel facility in Andhra Pradesh, targeting data centres and semiconductor plants.

Highway Infrastructure

• Deal: Signed a ₹220.66 crore contract with UPEIDA for toll operations on the Gorakhpur Link Expressway for two years. Stock closed at ₹42.75 in the previous session, down 1.18%.
• Management: AGM resolutions passed with over 99.98% votes in favor, including the reappointment of Anoop Agrawal as Whole Time Director and CFO.

North Eastern Carrying Corp.

• Order Book: Won a ₹78.19 crore transport order from Tata Steel for iron ore movement, representing roughly 62% of average quarterly revenue. Stock closed at ₹18.42 in the previous session, up 1.88%.
• Fund Raise: Board approved the allotment of 1 crore convertible warrants to promoter Sunil Kumar Jain at ₹18.51 per warrant.

NCC

• Order Book: Secured two contracts worth ₹500.22 crore in September and a massive ₹1,076.71 crore water supply project in Andhra Pradesh. Stock closed at ₹128.88 in the previous session, up 0.48%.
• Regulatory: Trading window closed from October 1 until 48 hours after Q2FY27 results declaration.

NLC India

• Order Book: Subsidiary NIRL won a bid for a 265 MW/530 MWh Battery Energy Storage System (BESS) project in Haryana. Stock closed at ₹261.70 in the previous session, up 2.33%.
• Deal: Board approved a 50:50 joint venture with Nalco to develop a 1,080 MW thermal captive power plant.
• Earnings: Q1FY27 PBT rose 9.8% YoY to ₹652 crore, while total power capacity reached 8.4 GW.

Cupid

• Guidance: Raised FY27 revenue forecast to over ₹800 crore and net profit target to over ₹250 crore following strong Q2 performance. Stock closed at ₹311.65 in the previous session, up 8.21%.
• Deal: Approved conversion of 30 lakh warrants in Baazar Style Retail into equity shares for approximately ₹73.86 crore.
• Management: Promoter Aditya Kumar Halwasiya increased his stake to 34.71% through open market purchases.

Symbiotec Pharmalab

• Regulatory: Received US FDA 'Voluntary Action Indicated' (VAI) status for its Pithampur plant, indicating no mandatory regulatory action is required. Stock closed at ₹1,176.75 in the previous session, up 2.84%.
• Deal: Subsidiary Knovea signed a commercialisation agreement with a global pharma major for dual chamber vial products in the US.

Aurobindo Pharma

• Product Launch: Subsidiary Acrotech Biopharma launched AdQuey ointment in the US, marking entry into the dermatology market. Stock closed at ₹1,672.00 in the previous session, down 1.51%.
• Regulatory: Confirmed a disputed GST demand of ₹4.60 crore for FY21, with plans to appeal before the GST Appellate Tribunal.

Bottom Line

The market's attention is squarely on growth visibility, with companies like Cupid and Interarch rallying on upgraded guidance and robust order books. Meanwhile, the energy sector shows strength as NLC India expands its renewable footprint through strategic bids and JVs, signaling continued investor appetite for capex-driven utilities.